NJ State Employees Deferred Compensation Plan - KARUNA THERAPEUTICS INC ownership

KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 257 filers reported holding KARUNA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.6%.

Quarter-by-quarter ownership
NJ State Employees Deferred Compensation Plan ownership history of KARUNA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$929,995
-22.0%
5,5000.0%0.14%
-18.0%
Q2 2023$1,192,675
+19.4%
5,5000.0%0.17%
+11.7%
Q1 2023$999,020
+64.0%
5,500
+77.4%
0.15%
+55.6%
Q4 2022$609,150
-12.6%
3,1000.0%0.10%
-16.8%
Q3 2022$697,0003,1000.12%
Other shareholders
KARUNA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Pivotal bioVenture Partners Investment Advisor LLC 797,008$134,766,08353.75%
Nan Fung Group Holdings Ltd 225,688$38,161,58430.90%
Sofinnova Investments, Inc. 1,381,149$233,538,48414.73%
First Light Asset Management, LLC 303,137$51,257,4354.87%
Altium Capital Management LP 34,000$5,749,0603.00%
DAFNA Capital Management LLC 52,873$8,940,2962.78%
Logos Global Management LP 115,000$19,445,3502.59%
GENERAL ATLANTIC, L.P. 986,710$166,842,7942.58%
MPM BioImpact LLC 53,210$8,997,2792.40%
Rock Springs Capital Management LP 505,433$85,463,6662.29%
View complete list of KARUNA THERAPEUTICS INC shareholders